Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Discovery themes featuring this stock| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
46.00 | 49 Cr | 9.30 | 1.18 | 0.00 | 12.66 | 16.31 | 11.55 | ||
45.00 | 48 Cr | 70.17 | 2.56 | 0.44 | 2.95 | 3.34 | 1.83 | ||
43.75 | 47 Cr | 5.27 | 0.95 | 0.00 | 17.98 | 23.26 | 12.85 | ||
153.05 | 47 Cr | -55.94 | 4.67 | 0.00 | -9.84 | -0.23 | -3.50 | ||
138.50 | 42 Cr | 12.44 | 4.20 | 1.08 | 27.45 | 38.11 | — | ||
118.65 | 36 Cr | 20.31 | 0.72 | 0.84 | 3.65 | 5.97 | 2.29 | ||
| Median: 6 Co. | — | 82.33 | 47 Cr | 10.87 | 1.87 | 0.22 | 8.15 | 11.14 | 2.29 |
Bearish
2
Neutral
6
Bullish
6
Bearish
20
Neutral
6
Bullish
20
Bearish
18
Neutral
0
Bullish
14
Bearish
18
Neutral
0
Bullish
14
Bearish
18
Neutral
0
Bullish
14
Bearish
18
Neutral
0
Bullish
14
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Crestchem Ltd (CRSTCHM) is currently trading at 143.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Crestchem Limited manufactures nutrition chemical products, primarily Caprylic/Capric Triglycerides in oil and powder forms and related downstream products used across industrial and other applications, operating from Gujarat with a subsidiary focused on MCT oil production. Financially, Crestchem reported strong quarter-on-quarter and year-on-year improvement: standalone revenue for quarter ended June 30, 2026 was Rs. 917.89 lakhs versus Rs. 503.09 lakhs a year earlier, with profit before tax rising to Rs. 136.19 lakhs, reflecting robust top-line growth and notable margin expansion. Strategically, the company is pivoting toward specialty chemicals and nutraceutical ingredients, having incorporated Oleo Biosciences Private Limited (75% owned) to establish an MCT oil manufacturing facility, a clear move to capture higher-value segments and enhance manufacturing control. The company remains a single-segment operator (Nutrition-Chemical Industries) with paid-up equity of Rs. 300.00 lakhs and small subsidiary scale: the newly included subsidiary reported revenue of Rs. 7.80 lakhs and a net loss of Rs. 4.13 lakhs for the quarter, keeping consolidated performance close to standalone. Corporate governance and disclosures show regular board action and a limited review by statutory auditors for the quarter ended June 30, 2026, indicating compliance with listing regulations while the company executes its growth and capacity expansion plans.
Over the past 52 weeks, Crestchem Ltd has traded between a low of ₹73.01 and a high of ₹185.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Crestchem Ltd has a market capitalization of approximately 41.55. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Crestchem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 15.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 41.55 Cr, Crestchem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Crestchem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Crestchem Ltd is 15.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Crestchem Limited manufactures nutrition chemical products, primarily Caprylic/Capric Triglycerides in oil and powder forms and related downstream products used across industrial and other applications, operating from Gujarat with a subsidiary focused on MCT oil production.
Financially, Crestchem reported strong quarter-on-quarter and year-on-year improvement: standalone revenue for quarter ended June 30, 2026 was Rs. 917.89 lakhs versus Rs. 503.09 lakhs a year earlier, with profit before tax rising to Rs. 136.19 lakhs, reflecting robust top-line growth and notable margin expansion.
Strategically, the company is pivoting toward specialty chemicals and nutraceutical ingredients, having incorporated Oleo Biosciences Private Limited (75% owned) to establish an MCT oil manufacturing facility, a clear move to capture higher-value segments and enhance manufacturing control.
The company remains a single-segment operator (Nutrition-Chemical Industries) with paid-up equity of Rs. 300.00 lakhs and small subsidiary scale: the newly included subsidiary reported revenue of Rs. 7.80 lakhs and a net loss of Rs. 4.13 lakhs for the quarter, keeping consolidated performance close to standalone.
Corporate governance and disclosures show regular board action and a limited review by statutory auditors for the quarter ended June 30, 2026, indicating compliance with listing regulations while the company executes its growth and capacity expansion plans.
Chemicals & Petrochemicals
Specialty Chemicals
42 Cr
High Risk
15.3
34.8
—
4.2
185.00
73.01
Sales CAGR
Profit CAGR
ROE
ROCE
